Clinical Outcomes of Patients with Rheumatoid Arthritis Treated in a Disease Management Program: Real-World Results

Open Access Rheumatology : Research and Reviews
Pedro Santos-MorenoOmaira Valencia

Abstract

Care models can affect the clinical outcome of patients with rheumatic and musculoskeletal diseases. We aimed to compare how an innovative model of a rheumatoid arthritis disease-management program can improve the clinical outcomes of patients compared to a conventional assessment approach. We performed a retrospective analysis of real-world data from clinical records of a cohort of 5078 patients diagnosed with rheumatoid arthritis who were followed up at the Center of Excellence in Rheumatoid Arthritis vs the clinical outcomes reported in the Colombian National Registry of Rheumatoid Arthritis. We found significant differences in the diagnosis and follow-up between the specialized Center program and the usual care reported by the Colombian National Registry (p<0.005), including the evaluation of rheumatoid factor, Anti-citrullinated antibodies Disease Activity Score, Health Assessment Questionnaire, number of visits to the rheumatologist, and clinical outcomes measured by the level of disease activity. In addition, when comparing the Center's clinical outcomes - from baseline to the last follow-up, we found an improvement in the level of disease activity, with patients classified in remission increasing from 20.8% to 58.5% (p<...Continue Reading

References

Jun 10, 2003·Arthritis and Rheumatism·Enkhe BadamgaravUNKNOWN Evidence-Based Medicine Working Groups in Rheumatology
Jul 2, 2003·Health and Quality of Life Outcomes·Bonnie Bruce, James F Fries
Apr 13, 2006·Clinical Rheumatology·Peter M Brooks
May 20, 2009·Clinical Orthopaedics and Related Research·Jon D LurieJim Weinstein
Sep 19, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·P A LairesJ E Fonseca
Aug 8, 2013·Annals of the Rheumatic Diseases·Michaela A StofferUNKNOWN eumusc.net-working group
Aug 24, 2013·Journal of Managed Care Pharmacy : JMCP·Patrick P GleasonNilay D Shah
Apr 17, 2015·Rheumatology·Victoria Navarro-CompánDésirée van der Heijde
Jul 26, 2015·Clinical Rheumatology·Pedro Santos-MorenoCarlos Castro
Dec 25, 2015·Best Practice & Research. Clinical Rheumatology·M J H VoshaarB J F van den Bemt
Dec 25, 2015·Best Practice & Research. Clinical Rheumatology·Sehrash MahmoodRobert Landewé
Oct 18, 2016·Drugs -- Real World Outcomes·Bruce C M WangChao-Hsiun Tang
Mar 30, 2018·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Pedro Santos-MorenoDiana Buitrago

❮ Previous
Next ❯

Methods Mentioned

BETA
MDA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved